Taiwan Bio Therapeutics Co., Ltd
6892
Rank in Stocks
#21101
Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative... Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative medicine, primarily dedicated to the development of novel cellular therapeutics. These advanced treatments are crafted to address a range of medical conditions, including degenerative disorders, cardiovascular ailments, complications stemming from diabetes, and autoimmune diseases. The company was established in 2014 and its operations are headquartered in Taipei City, Taiwan.
Share Price
$0.78040214
Last synced: 2026-11-10
Market Cap
$73.37M
Change (1 day)
-0.58%
Change (1 year)
-18.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiwan Bio Therapeutics Co., Ltd (6892)
Category
Healthcare
Operating Margin for Taiwan Bio Therapeutics Co., Ltd (6892)
Operating Margin as of November 2026 TTM: -764.16%
According to Taiwan Bio Therapeutics Co., Ltd's latest financial reports, its current operating margin (TTM) is -764.16%. At the end of 2025 the company had an operating margin of -764.16%.
Operating Margin history for Taiwan Bio Therapeutics Co., Ltd from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -764.16% | 0.00% |
| 2025 | -764.16% | 128.51% |
| 2024 | -334.41% | 34.69% |
| 2023 | -248.28% | -39.16% |
| 2022 | -408.09% | 26.89% |
| 2021 | -321.61% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.05% |
US
|
|
| -149.01% | -99.81% |
US
|
|
| 25.57% | -100.03% |
AU
|
|
| 31.23% | -100.04% |
BE
|
|
| 29.35% | -100.04% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Taiwan Bio Therapeutics Co., Ltd's operating margin
What is Taiwan Bio Therapeutics Co., Ltd's operating margin?
Taiwan Bio Therapeutics Co., Ltd's operating margin is -764.16%, as of Nov 2026.
What was Taiwan Bio Therapeutics Co., Ltd's operating margin in 2025?
In 2025, Taiwan Bio Therapeutics Co., Ltd's operating margin was -764.16%, compared with -334.41% in 2024.
How has Taiwan Bio Therapeutics Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, Taiwan Bio Therapeutics Co., Ltd's operating margin was highest in 2020 (0.00%) and lowest in 2025 (-764.16%).
How does Taiwan Bio Therapeutics Co., Ltd's operating margin compare with similar companies?
Taiwan Bio Therapeutics Co., Ltd's operating margin (-764.16%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.